Regulation of P2X7 gene transcription

Purinergic Signalling

Volumn 5, Issue 3, 2009, Pages 409-426

  Zhou, Lingyin ^a   Luo, Liping ^a   Qi, Xiaoping ^a   Li, Xin ^a   Gorodeski, George I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cervical; Cervix; CpG; Enhancer; Inhibition; Methylation

Indexed keywords

EID: 68349144588     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-009-9167-x     Document Type: Article

References (78)

1. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306
2. Ellis HM, Yuan J, Horvitz HR (1991) Mechanisms and functions of cell death. Annul Rev Cell Biol 7:663-698
3. Fawthrop DJ, Boobis AR, Davies DS (1991) Mechanisms of cell death. Arch Toxicol 65:437-444
4. 7-receptor mediated apoptosis of human cervical epithelial cells. Am J Physiol 287:C1349-C1358
5. Soti C, Sreedhar AS, Csermely P (2003) Apoptosis, necrosis and cellular senescence: Chaperone occupancy as a potential switch. Aging Cell 2:39-45
6. Renvoize C, Biola A, Pallardy M, Breard J (1998) Apoptosis: identification of dying cells. Cell Biol Toxicol 14:111-120
7. 7 receptor: A novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomark Prev 15:1-8
8. 7-receptor mediated pore formation and apoptosis: A novel signaling network. Endocrinology 146:164-174
9. Fu W, McCormick T, Qi X, Luo L, Zhou L, Li X, Wang BC, Gibbons HE, Abdul-Karim FW, Gorodeski GI (2009) Activation of P2X7-mediated apoptosis inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice. BMC Cancer 9:114
10. Greig AV, Linge C, Healy V, Lim P, Clayton E, Rustin MH, McGrouther DA, Burnstock G (2003) Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 121:315-327
11. 7 receptor through hetero-oligomerization. J Biol Chem 281:17228-17237
12. 7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106:233-243
13. 7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 283:28274-28286
14. 7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric-duct origin. Purinergic Signalling, in press. doi: 10.1007/s11302-009-9161-3
15. Dubyak GR, el-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577-C606
16. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
17. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
18. Sperlágh B, Haskó G, Németh Z, Vizi ES (1998) ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int 33:209-215
19. Grahames CBA, Michel AD, Chessell IP, Humphrey DPA (1999) Pharmacological characterization of ATP- and LPS-induced IL-1β release in human monocytes. Br J Pharmacol 127:1915-1921
20. Henriksen KL, Novak I (2003) Effect of ATP on intracellular pH in pancreatic ducts involves P2X7 receptors. Cell Physiol Biochem 13:93-102
21. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG (2003) Hypertonic stress increases T-cell Interleukin-2 expression through a mechanism that involves ATP release, P2 Receptor, and p38 MAPK activation. J Biol Chem 278:4590-4596
22. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458
23. Aggarwal BB, Rath PC (1999) TNF-induced signaling in apoptosis. J Clin Immunol 19:350-364
24. Humphreys BJ, Rice J, Kertesy SB, Dubyak GR (2000) Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275:26792-26798
25. Ferrari D, Wesselborg S, Bauer MK, Schulze-Osthoff K (1997) Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65. J Cell Biol 139:1635-1643
26. Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE (1998) Gene structure and chromosomal localization of the human P2X7 receptor. Recept Channels 5:347-354
27. Li CM, Campbell SJ, Kumararatne DS, Bellamy R, Ruwende C, McAdam KP, Hill AV, Lammas DA (2002) Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis 186:1458-1462
28. 7 promoter. FEBS Letters 531:127-131
29. Denlinger LC, Coursin DB, Schell K, Angelini G, Green DN, Guadarrama AG, Halsey J, Prabhu U, Hogan KJ, Bertics PJ (2006) Human P2X7 pore function predicts allele linkage disequilibrium. Mol Diagnostics Gen 52:995-1004
30. Gasser S, Raulet D (2006) The DNA damage response, immunity and cancer. Semin Cancer Biol 16:344-347
31. Kujoth GC, Leeuwenburgh C, Prolla TA (2006) Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res 66:7386-7389
32. Rodriguez-Nieto S, Zhivotovsky B (2006) Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 12:4411-25
33. Gustafson KS, Furth EE, Heitjan DF, Fansler ZB, Clark DP (2004) DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: An approach that utilizes receiver-operating characteristic analysis. Cancer Cytopathol 102:259-268
34. Li J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS (2005) IGSF4 promoter methylation and expression silencing in human cervical cancer. Gynecol Oncol 96:150-158
35. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 97:273-282
36. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomark Prev 15:114-123
37. Bhattacharjee B, Sengupta S (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354:280-285
38. Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, Kim KT (2006) Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: Correlation with clinicopathologic characteristics. Int J Gynecol Cancer 16:1234-1240
39. Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP (2006) Comparison of DNA hypermethylation patterns in different types of uterine cancers: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 118:2168-2171
40. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, Termrungruanglert W, Tresukosol D, Niruthisard S, Mutirangura A (2006) Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 6:55
41. Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B, Murty VV (2006) Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. BMC Molecular Cancer 5:16
42. Okino K, Nagai H, Nakayama H, Doi D, Yoneyama K, Konishi H, Takeshita T (2006) Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma. Int J Gynecol Cancer 16:763-71
43. Wisman GBA, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AGJ (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119:1908-1914
44. Yang HJ, Liu VWS, Wang Y, Tsang PCK, Ngan HYS (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 6:212
45. Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY (2007) Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 104:629-635
46. Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, Higashimoto K, Noguchi M, Yokoyama M, Iwasaka T, Mukai T (2007) Retinoic acid receptor β2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Lett 247:318-327
47. Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D (2002) Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomark Prev 11:3-6
48. Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V, Kisseljov F, Kisseljova N (2002) Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer. BMC Cancer 2:4
49. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol Cancer 2:24
50. Xiong Z, Laird PW (1997) COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acid Res 25:2532-2534
51. Chen T, Li E (2006) Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol 301:179-201
52. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070
53. Comb M, Goodman HM (1990) CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18:3975-3982
54. Hendrich B, Tweedie S (2003) The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19:269-277
55. Wade PA (2001) Methyl CpG binding proteins: Coupling chromatin architecture to gene regulation. Oncogene 20:3166-3173
56. Bird AP, Wolffe AP (1999) Methylation-induced repression: Belts, braces, and chromatin. Cell 99:451-444
57. Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JPJ (2004) Hypermethylation and silencing of the putative tumor suppressor tazarotene-induced gene 1 in human cancers. Cancer Res 64:2411-2417
58. Youssef EM, Estecio MR, Issa JP (2004) Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer. Cancer Biol Ther 3:82-86
59. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JPJ (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J Nat Cancer Inst 97:1330-1338
60. Tryndyak V, Kovalchuk O, Pogribny IP (2006) Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells. Anal Biochem 356:202-207
61. Plass C, Soloway PD (2002) DNA methylation, imprinting and cancer. Eur J Hum Genet 10:6-16
62. Villagra A, Gutierrez J, Paredes R, Sierra J, Puchi M, Imschenetzky M, Wijnen Av A, Lian J, Stein G, Stein J, Montecino M (2002) Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem 85:112-122
63. Farré D, Roset R, Huerta M, Adsuara JE, Roselló L, Albà MM, Messeguer X (2003) Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 31:3651-3653
64. Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277:50607-50611
65. Yang SH, Sharrocks AD (2006) Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochem Soc Symp 73:121-129
66. Yang Q, Kardava L, St Leger A, Martincic K, Varnum-Finney B, Bernstein ID, Milcarek C, Borghesi L (2008) E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J Immunol 181:5885-5894
67. Mathis DJ, Elkaim R, Kédinger C, Sassone-Corsi P, Chambon P (1981) Specific in vitro initiation of transcription on the adenovirus type 2 early and late EII transcription units. Proc Natl Acad Sci USA 78:7383-7387
68. Hamel PA, Gill RM, Phillips RA, Gallie BL (1992) Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol 12:3431-3438
69. Zheng N, Fraenkel E, Pabo CO, Pavletich NP (1999) Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev 13:666-674
70. Pardee AB, Li CJ, Reddy GP (2004) Regulation in S phase by E2F. Cell Cycle 3:1091-1094
71. Laptenko O, Prives C (2006) Transcriptional regulation by p53: One protein, many Possibilities. Cell Death Differ 13:951-961
72. Schulze-Lohoff E, Hugo C, Rost S, Arnold S, Gruber A, Brüne B, Sterzel RB (1998) Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol 275:F962-F971
73. Turner CM, Tam FWK, Lai PC, Tarzi RM, Burnstock G, Pusey CD, Cook HT, Unwin RJ (2007) Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant 22:386-395
74. Cheewatrakoolpong B, Gilchrest H, Anthes JC, Greenfeder S (2005) Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Comm 332:17-27
75. Georgiou JG, Skarratt KK, Fuller SJ, Martin CJ, Christopherson RI, Wiley JS, Sluyter R (2005) Human epidermal and monocyte-derived langerhans cells express functional P2X receptors. J. Invest Dermatol 125:482-490
76. Kim M, Spelta V, Sim J, North RA, Surprenant A (2001) Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery. J Biol Chem 276:23262-23267
77. Locovei S, Scemes E, Qiu F, Spray DC, Dahl G (2007) Pannexin1 is part of the pore forming unit of the P2X7R death complex. FEBS Lett 581:483-488
78. 7 receptor-pannexin1 complex: Pharmacology and signaling. Am J Physiol 295:C752-C760